North America
- Action
- Alert
- Class
- correct success
- credit score
- deadline
- Finance
- Finance
- Firm
- Investment
- Law
- Lawsuit
- Losses
- nasdaq-nms:rvnc
- new york
- North America
- north east
- Pomerantz
- Reminds
- Revance
- RVNC
- Shareholder
- Shareholders
- Therapeutics
- United States of America
- Upcoming


NEW YORK, Jan. 17, 2022 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-09585, is on […]
- BioNTech SE ADR
- Biotech and Pharma
- BNTX
- china
- clothing
- Clothing/Textiles
- Consumer Goods
- Coronavirus
- correct success
- Delays
- Entertainment
- epidemics
- facebook new name
- FB
- Finance
- Financial manageme
- Financial success
- General News
- Health
- Healthcare
- Healthcare/Life Sciences
- Immunizations
- Infectious Diseases
- life sciences
- March
- Markets
- Media
- Media/Entertainment
- Medical Conditions
- medical treatments
- Medical Treatments/Procedures
- medications
- meta
- meta facebook
- meta platforms
- Meta Platforms Inc
- moderna
- Moderna Inc
- money
- MRNA
- North America
- Novel Coronaviruses
- Office
- Omicron
- Online Service Providers
- outbreaks
- Outbreaks/Epidemics
- PFE
- Pfizer
- PFIZER INC
- Pharmaceuticals
- Political
- Political/General News
- Procedures
- ready
- Respiratory Tract Diseases
- Retail
- Retail/Wholesale
- return
- social media platforms
- Social Media Platforms/Tools
- specialized drugs
- Specialized Drugs/Medications
- SYND
- technology
- Textiles
- tools
- vaccine
- vaccines
- wholesale
- Wholesalers


Text size Pfizer says its Omicron-targeting vaccine should be ready by March. Patrick T. Fallon/AFP via Getty Images Pfizer said it should be able to launch a redesigned Covid-19 vaccine that targets the Omicron variant of the virus by March, while Facebook parent Meta Platforms delayed its U.S. office reopening plans and mandated booster shots […]
- 100K
- Action
- Class
- Commenced
- correct success
- Counsel
- deadline
- December
- encourages
- facebook new name
- FB
- filed
- Finance
- Financial manageme
- Financial success
- Firm
- fka
- important
- Investor
- investors
- Losses
- meta
- meta facebook
- meta platforms
- money
- nasdaq-nms:fb
- new york
- North America
- north east
- platforms
- Rosen
- Secure
- securities
- Skilled
- state
- United States of America


NEW YORK, Dec. 14, 2021 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meta Platforms, Inc. f/k/a Facebook, Inc. (NASDAQ: FB) (“Facebook”) between November 3, 2016 and October 4, 2021, inclusive (the “Class Period”), of the important December 27, 2021 lead plaintiff deadline in the securities class […]
- Action
- Bernstein
- bernstein liebhard llp
- Class
- Class Action
- company
- correct success
- deadline
- facebook inc.
- facebook new name
- FB
- file
- Finance
- Financial manageme
- Financial success
- fka
- Investor
- investors
- Law
- Lawsuit
- lead
- Liebhard
- LLP
- meta
- meta facebook
- meta platforms
- money
- motion
- NASDAQ
- nasdaq-nms:fb
- new york
- North America
- north east
- Plaintiff
- platforms
- Reminds
- securities
- Shareholder
- state
- United States of America


NEW YORK, Nov. 30, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights legislation agency, reminds traders of the deadline to file a lead plaintiff movement no later than December 27, 2021 in a securities class motion lawsuit that has been filed on behalf of traders who bought or acquired the securities of Meta […]
Pages
- 1